Paradigm Biocapital Advisors LP
- SEC CIK
- 0001855655
- Latest filing
- Aug 14, 2026
ERAS holding history
Erasca, Inc. in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ERAS overviewAll 13F holders of ERASFull Q2 2026 holdings
- Shares (Q2 2026)
- 9,550,000
- Value
- $175.0M
- % of portfolio
- 3.3%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 9,550,000 | $175.0M | 3.3% | −842,702−8.1% | Reduced | Holders |
| Q1 2026 | 10,392,702 | $168.2M | 3.4% | −3,766,393−26.6% | Reduced | Holders |
| Q4 2025 | 14,159,095 | $52.7M | 1.4% | +599,078+4.4% | Added | Holders |
| Q3 2025 | 13,560,017 | $29.6M | 0.9% | +1,652,835+13.9% | Added | Holders |
| Q2 2025 | 11,907,182 | $15.1M | 0.6% | +1,104,828+10.2% | Added | Holders |
| Q1 2025 | 10,802,354 | $14.8M | 0.7% | +50,000+0.5% | Added | Holders |
| Q4 2024 | 10,752,354 | $27.0M | 0.9% | +84,213+0.8% | Added | Holders |
| Q3 2024 | 10,668,141 | $29.1M | 1.0% | +3,418,141+47.1% | Added | Holders |
| Q2 2024 | 7,250,000 | $17.1M | 0.7% | +7,250,000 | New | Holders |